Atlas Trials

A Study of Safety and Efficacy Comparing ABT-874 Versus Methotrexate in Subjects With Moderate to Severe Plaque Psoriasis

Clinical trial NCT00679731 · COMPLETED

Trial details

NCT number
NCT00679731
Sponsor
AbbVie (prior sponsor, Abbott)
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Psoriasis
Start date
2008-04-01
Primary completion
2009-11-01
Enrollment
317

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.